All Stories

  1. Rational Approach to a Patient with Suspected Primary Aldosteronism

    Article • June 2017, IntechOpen

    Tomaž Kocjan

  2. MiR-148a the epigenetic regulator of bone homeostasis is increased in plasma of osteoporotic postmenopausal women

    Article • Wiener klinische Wochenschrift, November 2016, Springer Science + Business Media

    Tomaž Kocjan

  3. Outcome parameters in orthogeriatric co‑management – a mini-review

    Article • Wiener klinische Wochenschrift, November 2016, Springer Science + Business Media

    Tomaž Kocjan

  4. A NEW CLINICAL PREDICTION CRITERION ACCURATELY DETERMINES A SUBSET OF PATIENTS WITH BILATERAL PRIMARY ALDOSTERONISM BEFORE ADRENAL VENOUS SAMPLING

    Article • Endocrine Practice, May 2016, AACE Corp (American Association of Clinical Endocrinologists)

    Tomaž Kocjan

  5. Fracture Rate, Quality of Life and Back Pain in Patients with Osteoporosis Treated with Teriparatide: 24-Month Results from the Extended Forsteo Observational Study (ExFOS)

    Article • Calcified Tissue International, April 2016, Springer Science + Business Media

    Tomaž Kocjan, Francisco Marin

  6. Short term monotherapy with GLP-1 receptor agonist liraglutide or PDE 4 inhibitor roflumilast is superior to metformin in weight loss in obese PCOS women: a pilot randomized study

    Article • Journal of Ovarian Research, June 2015, Springer Science + Business Media

    Tomaž Kocjan

  7. Optimal scan time for evaluation of parathyroid adenoma with [18F]-fluorocholine PET/CT

    Article • Radiology and Oncology, January 2015, De Gruyter

    Tomaž Kocjan

  8. Short-term intervention with liraglutide improved eating behavior in obese women with polycystic ovary syndrome

    Article • Endocrine Research, October 2014, Informa Healthcare

    Tomaž Kocjan

  9. Phosphodiesterase 4 Inhibition as a Potential New Therapeutic Target in Obese Women With Polycystic Ovary Syndrome

    Article • The Journal of Clinical Endocrinology & Metabolism, August 2014, Endocrine Society

    Tomaž Kocjan

  10. 18F-Fluorocholine PET/CT for localization of hyperfunctioning parathyroid tissue in primary hyperparathyroidism: a pilot study

    Article • European Journal of Pediatrics, July 2014, Springer Science + Business Media

    Tomaž Kocjan

  11. Study description and baseline characteristics of the population enrolled in the extended forsteo[reg] observational study (ExFOS)

    Article • Bone Abstracts, May 2013, Bioscientifica

    Tomaž Kocjan

  12. Dihydrotachysterol intoxication treated with pamidronate: a case report

    Article • Cases Journal, January 2010, Springer Science + Business Media

    Tomaž Kocjan

  13. Analysis of Association of LRP5, LRP6, SOST, DKK1, and CTNNB1 Genes with Bone Mineral Density in a Slovenian Population

    Article • Calcified Tissue International, November 2009, Springer Science + Business Media

    Tomaž Kocjan

  14. APPROACH TO THE POSTMENOPAUSAL WOMAN WITH OSTEOPOROSIS IN SLOVENIA

    Article • Maturitas, May 2009, Elsevier

    Tomaž Kocjan

  15. Decreased Androgen Levels and Improved Menstrual Pattern after Angiotensin II Receptor Antagonist Telmisartan Treatment in Four Hypertensive Patients with Polycystic Ovary Syndrome: Case Series

    Article • Croatian Medical Journal, December 2007, Croatian Medical Journal

    Tomaž Kocjan

  16. Vitamin D Status in Patients with Osteopenia or Osteoporosis – an Audit of an Endocrine Clinic

    Article • International Journal for Vitamin and Nutrition Research, September 2006, Hogrefe Publishing Group

    Tomaž Kocjan

  17. Hormone replacement therapy update: who should we be prescribing this to now?

    Article • Current Opinion in Obstetrics & Gynecology, December 2003, Wolters Kluwer Health

    Tomaž Kocjan

  18. Changes in Th1/Th2 cytokine balance in Graves’ desease

    Article • Pflügers Archiv - European Journal of Physiology, January 2000, Springer Science + Business Media

    Tomaž Kocjan